One hundred people attended AICC’s Lunch reception for the 19 Israeli Companies attending the BIO Conference in Atlanta.
The lunch was hosted at the Atlanta Metro Chamber and was co-sponsored by US-Israel Science & Technology Foundation, Arnall Golden Gregory, Israel Life Science Industry, Office of the Israel Chief Scentist, Israel Economic Mission to the Southern Region, Georgia BIO, Matimop, Georgia Department of Economic Development, Bird Foundation, and the American-Israel Educational Institute, Southeast, Inc.
Charlie Harrison, President of Wynden Pharmaceuticals and AICC Medical Committee Chairman MC’ed the event.
Dr. Eli Opper, Israel’s Chief Scientist encouraged investments in life science companies despite of the global economic crisis.
Dr. Eric Tomlinsion, President & CEO of Altea Therapeutics, on behalf of GeorgiaBIO, highlighted the points of growth for the life science industriy in Georgia.